Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Trojanowski Neurolog AB
AB
Active
Org 5567532626
Drottningholmsvägen 322, 167 31
Bromma
Medical specialists activities
· NACE 8622
Est. 2008
2 employees
Watchlist
Share
Sweden
/
Companies
/
Medical specialists activities
/
Trojanowski Neurolog AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
1M
2M
3M
3M
3M
2021
3M
2022
3M
2023
2M
2024
1M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
1M
2021
1M
2022
0M
2023
0M
2024
0M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
3 470
3 491
2 929
1 557
1 141
Staff expenses
—
—
—
—
—
EBITDA
570
623
−445
−459
51
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
570
623
−445
−459
51
Net financials
161
139
252
3
−3
Profit before tax
731
761
−194
−456
48
Tax
−157
−157
−0
−0
−0
Net profit
574
604
−194
−456
48
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
1 418
1 318
527
325
494
Equity
676
780
86
130
178
Long-term debt
0
0
0
0
0
Short-term debt
742
538
441
195
317
Total debt
742
538
441
195
317
Financial ratios
5-year trend
EBITDA margin
4.5%
This company
15.8%
Market median
-72% vs market
2021
2025
Equity ratio
36.0%
This company
38.2%
Market median
+6% vs market
2021
2025
Return on equity
27.0%
This company
18.4%
Market median
+47% vs market
2021
2025
Net profit margin
4.2%
This company
8.1%
Market median
-48% vs market
2021
2025
Asset turnover
2.31×
This company
1.12×
Market median
+106% vs market
2021
2025
Debt / equity
1.78×
This company
0.62×
Market median
-187% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
View
PDF
More on Trojanowski Neurolog AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network